Search

Search Results

• The SGLT-2 Inhibitors and their Role in the Treatment of Heart Failure - A Review of Literature

  Silvia Ciraolo, Agnieszka Kulczycka-Rowicka, Joanna Wojda, Katarzyna Lesiczka-Fedoryj, Anna Walczak, Zuzanna Kościuszko, Adam Sobiński, Matylda Czerwonka, Katarzyna Kurza, Julianna Podolec

  58178

  2025-02-11
• Flozins in Reducing Cardiovascular and Metabolic Risk: A Literature Review

  Daria Sieniawska, Julia Sieniawska, Patrycja Proszowska

  52540

  2024-07-08
• Flozins - modern treatment for patients with type 2 diabetes

  Dominik Augustyn, Krzysztof Pawlikowski, Michał Korpalski, Marek Żygłowicz, Mateusz Marciniak, Adam Torbicki, Piotr Gaworek, Maria Pawluczyk, Alicja Trybuła

  61318

  2025-07-07
• Gliflozins and their beneficial hypoglycaemic effect profile and prevention of cardiovascular complications in patients treated for type II diabetes mellitus

  Natalia Sobańska, Rafał Teichman, Aleksandra Paulina Banasiak, Jakub Kasprowicz, Jakub Rafał Pierzchała, Michał Hyjek, Kamila Abram, Patryk Banaś, Katarzyna Bednarz, Justyna Adamus

  11-17

  2023-02-18
• Sodium–glucose co-transporter-2 inhibitors - empagliflozin and dapagliflozin as future therapy for Alport Syndrome, literature review

  Magdalena Kłusek, Katarzyna Chawrylak, Julia Kuszneruk, Maria Kubas, Katarzyna Krzemińska

  53252

  2024-07-25
• SGLT-2 inhibitors in heart failure: a literature review on mechanisms, efficacy and safety

  Klaudia Kułak, Katarzyna Chamera-Cyrek, Izabela Janik, Martyna Kuśmierska, Anna Koman, Marzena Pliszka, Katarzyna Gadżała, Karolina Palacz, Izabela Sztybór, Sabina Przygodzka

  52083

  2024-07-05
• Changes in the Treatment and Prevention of Heart Failure Based on the 2023 Focused Update of the 2021 European Society of Cardiology Guidelines

  Joanna Skotnicka, Karolina Błaszczak, Maria Witkowska, Monika Turek, Maciej Witkowski, Tymoteusz Ślósarz, Paulina Krupa, Rafal Kaczorowski, Tomasz Forenc, Klara Wojciechowska

  54787

  2024-10-07
• Synergy of pharmacotherapy and physical activity in the treatment of obesity and cardiovascular prevention in patients with type 2 diabetes

  Karolina Mędrysa, Marlena Jankowska, Karolina Baran, Natalia Jańczyk, Gabriela Blecharz, Michał Presak, Katarzyna Bartnik, Jakub Jan Pokrzepa, Julia Szwech, Mikołaj Pograniczny

  60480

  2025-06-11
• Treatment of NAFLD: Diet, Physical Activity, and Potential Pharmacological Options

  Justyna Śliz, Natalia Aleksandra Popławska, Marta Skorupska, Magdalena Joanna Czeczotka, Krzysztof Woźniak, Martyna Magdalena Martka

  52219

  2024-07-07